Hyperglycemia and hypertriglyceridemia secondary to olanzapine.
D000293:Adolescent; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced*; D015228:Hypertriglyceridemia / Q000139:chemically induced*; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use